SAM
STRO icon

Sectoral Asset Management’s Sutro Biopharma STRO Stock Holding History

Sectoral Asset Management’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-62,368
Closed -$2.68M – 108
2023
Q4 		$2.68M Buy
62,368
+19,134
+44% +$607K 1.15% 30
2023
Q3 		$1.5M Buy
43,234
+3,169
+8% +$138K 0.29% 93
2023
Q2 		$1.86M Buy
+40,065
New +$1.99M 0.31% 91

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Sectoral Asset Management's STRO Position: Q1 2024 in Review

Sectoral Asset Management sold out of Sutro Biopharma (STRO) in Q1 2024, closing a stake of 62,368 shares — an estimated $2.68M sold.

Sectoral Asset Management first reported a position in STRO in Q2 2023 and held it in 3 quarters. The position peaked at $2.68M in Q4 2023. 117 funds tracked by Wall St. Rank hold STRO as of Q1 2024.

  • Sectoral Asset Management reported no remaining Sutro Biopharma position as of Q1 2024 after selling out during the quarter.
  • Sectoral Asset Management sold 62,368 Sutro Biopharma shares in Q1 2024, an estimated $2.68M.
  • Sectoral Asset Management first reported a position in Sutro Biopharma in Q2 2023 and held it in 3 quarters.
  • Sectoral Asset Management's Sutro Biopharma position peaked at $2.68M in Q4 2023.
  • 117 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2024.

Based on Sectoral Asset Management's 13F filing for Q1 2024, filed 14 May 2024.